Altium Capital Management’s ESSA Pharma EPIX Stock Holding History

Altium Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,050,369	Closed	-$1.66M	–	6
2025 Q1	$1.66M	Sell	1,050,369 -377,631	-26%	-$639K	4.82%	9
2024 Q4	$2.56M	Buy	+1,428,000	New	+$4.55M	0.8%	46
2022 Q1	–	Sell	-345,000	Closed	-$4.9M	–	130
2021 Q4	$4.9M	Buy	+345,000	New	+$3.84M	1.38%	25
2021 Q3	–	Sell	-213,528	Closed	-$6.1M	–	133
2021 Q2	$6.1M	Sell	213,528 -16,535	-7%	-$481K	1.41%	14
2021 Q1	$6.68M	Buy	230,063 +54,996	+31%	+$1.28M	1.86%	5
2020 Q4	$2.09M	Buy	+175,067	New	+$1.23M	0.78%	54

Other funds holding EPIX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

DLD Asset Management New York $986M AUM 4.68% 1-Year Est. Return